Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/18253
Type
ArticleCopyright
Restricted access
Embargo date
2039-01-01
Collections
Metadata
Show full item record
COST-EFFECTIVENESS ANALYSIS OF DIAGNOSTIC TESTS FOR HUMAN VISCERAL LEISHMANIASIS IN BRAZIL
Author
Affilliation
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Pesquisas Clínicas. Belo Horizonte, MG, Brazil/Centro Federal de Educação Tecnológica de Minas Gerais. Contagem, MG, Brazil.
Instituto para Avaliação de Tecnologias em Saúde. Porto Alegre, RS, Brazil/Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brazil
Universidade do Estado do Rio de Janeiro. Instituto de Medicina Social. Departamento de Epidemiologia. Rio de Janeiro, RJ, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Pesquisas Clínicas Belo Horizonte, MG, Brazil
Instituto para Avaliação de Tecnologias em Saúde. Porto Alegre, RS, Brazil/Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brazil
Universidade do Estado do Rio de Janeiro. Instituto de Medicina Social. Departamento de Epidemiologia. Rio de Janeiro, RJ, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Pesquisas Clínicas Belo Horizonte, MG, Brazil
Abstract
BACKGROUND: The objective of study was to estimate the incremental cost-effectiveness ratio (ICER) of diagnostic options for visceral leishmaniasis (VL) in Brazil.
METHODS: Six diagnostic tests were considered: IT LEISH, Kalazar Detect, DAT-LPC (DAT made in the Laboratório de Pesquisas Clínicas), IFAT, PCR and direct examination of bone marrow aspirate performed in either an ambulatory or a hospital setting. A database was built using the cost and effectiveness. The perspective of this study was the Brazilian public healthcare system and the results were expressed in costs per correctly diagnosed cases.
RESULTS: In a favorable hypothetical scenario, DAT-LPC presented the lowest cost (US$4.92) and highest effectiveness (99%). Paired analyses showed that IT LEISH was dominant compared to IFAT, microscopy and Kalazar Detect and that Kalazar Detect was dominant over IFAT and microscopy. PCR was dominant over the bone marrow aspirate in the hospital and showed an ICER of 57.76 compared with aspirate in an ambulatory setting.
CONCLUSIONS: These results highlight the need for the revision of algorithm for VL diagnostic in Brazil. Replacements of IFAT with DAT-LPC, Kalazar Detect with IT LEISH and bone marrow aspirate performed in a hospital setting with PCR are cost-effective public health measures.
Share